New advances made in gene therapy for HIV

An early-stage trial has provided some important proof that gene therapy could be an effective way to fight HIV. Taking five patients who had already failed to respond to standard therapies, the researchers removed immune cells from each of the participants and injected modified lentivirus in each, changing the genetic code of the DNA of the cell so it can fight HIV and prevent the infection from spreading. In Phase II, a larger number of volunteers with HIV will get more than one infusion of the modulated cells. The scientists, led by Dr. Carl June, found that one of the volunteers responded with a significant reduction in the virus while immune cells multiplied and the immune system strengthened in the other four. The fact that they can introduce genes into cells without toxicity or provoking cancer, as has happened in earlier trials, is exactly the kind of proof of concept that gene therapy experts have been working toward.

- read the Washington Post report on gene therapy

Suggested Articles

Mutations in the ALK gene have been linked to cancer, but some variants may play a part in resistance to obesity, scientists have found.

DNA vaccines against COVID-19 generated protective levels of neutralizing antibodies in macaques, Harvard scientists said, but questions remain.

Using progenitor glial cells to regenerate myelin, the protective sheath around axons that's lost in MS, restored motor functions in mouse models.